{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:48:28Z","timestamp":1767084508719},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.amepre.2016.08.031","type":"journal-article","created":{"date-parts":[[2016,10,9]],"date-time":"2016-10-09T08:44:49Z","timestamp":1476002689000},"page":"362-372","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["National and State-Specific Shingles Vaccination Among Adults Aged \u226560 Years"],"prefix":"10.1016","volume":"52","author":[{"given":"Peng-jun","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa","family":"O\u2019Halloran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Harpaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amepre.2016.08.031_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.amepre.2016.08.031_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/421942","article-title":"Acute pain in herpes zoster and its impact on health related quality of life","volume":"39","author":"Katz","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amepre.2016.08.031_bib3","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amepre.2016.08.031_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"suppl 1","key":"10.1016\/j.amepre.2016.08.031_bib5","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1002\/jmv.10364","article-title":"Varicella in Americans from NHANES III: implications for control through routine immunization","volume":"70","author":"Kilgore","year":"2003","journal-title":"J Med Virol"},{"issue":"05","key":"10.1016\/j.amepre.2016.08.031_bib6","first-page":"1","article-title":"Prevention of herpes zoster recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.amepre.2016.08.031_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00019053-200725020-00007","article-title":"Acute\/subacute herpes zoster: healthcare resource utilization and costs in a group of U.S. health plans","volume":"25","author":"Insinga","year":"2007","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.amepre.2016.08.031_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S095026880400281X","article-title":"Incidence of herpes zoster, 1997\u20142002","volume":"133","author":"Mullooly","year":"2005","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.amepre.2016.08.031_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s15010-013-0550-8","article-title":"Incidence of herpes zoster in patients with altered immune function","volume":"42","author":"Chen","year":"2014","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.amepre.2016.08.031_bib10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","article-title":"Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination","volume":"52","author":"Leung","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amepre.2016.08.031_bib11","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.amepre.2016.08.031_bib12","unstructured":"Soni A, Hill SC. Average annual health care use and expenses for HZ among the U.S. civilian noninstitutionalized population, 2003\u20132005. Statistical brief #194. Rockville, MD: Agency for Healthcare Research and Quality. www.meps.ahrq.gov\/mepsweb\/data_stats\/Pub_ProdResults_Details.jsp?pt=Statistical%20Brief&opt=2&id=842. Published December 2007. Accessed February 8, 2016."},{"issue":"49","key":"10.1016\/j.amepre.2016.08.031_bib13","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","article-title":"Evaluation of the cost-effectiveness in the U.S. of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"25","author":"Pellissier","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2016.08.031_bib14","unstructured":"WebMD. Shingles vaccine to be routine at 60. www.webmd.com\/skin-problems-and-treatments\/shingles\/news\/20061025\/shingles-vaccine-to-be-routine-at-60. Accessed August 11, 2016."},{"issue":"10","key":"10.1016\/j.amepre.2016.08.031_bib15","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1086\/514342","article-title":"Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"44","author":"Rothberg","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.amepre.2016.08.031_bib16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.vaccine.2014.01.058","article-title":"Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review","volume":"32","author":"Kawai","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2016.08.031_bib17","unstructured":"CDC. BRFSS: overview\u2013BRFSS 2014. www.cdc.gov\/brfss\/annual_data\/2014\/pdf\/Overview_2014.pdf. Accessed February 8, 2016."},{"issue":"22","key":"10.1016\/j.amepre.2016.08.031_bib18","first-page":"410","article-title":"Methodological changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2016.08.031_bib19","unstructured":"CDC. BRFSS\u20142014 summary data quality report. www.cdc.gov\/brfss\/annual_data\/2014\/pdf\/2014_dqr.pdf. Accessed February 8, 2016."},{"key":"10.1016\/j.amepre.2016.08.031_bib20","series-title":"SUDAAN user\u2019s manual, release 11.01","author":"Shah","year":"2016"},{"key":"10.1016\/j.amepre.2016.08.031_bib21","unstructured":"U.S. DHHS. Immunization and infectious diseases. www.healthypeople.gov\/2020\/topics-objectives\/topic\/immunization-and-infectious-diseases\/objectives. Accessed February 10, 2016."},{"issue":"1","key":"10.1016\/j.amepre.2016.08.031_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6501a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2014","volume":"65","author":"Williams","year":"2016","journal-title":"MMWR Surveill Summ"},{"issue":"suppl 4","key":"10.1016\/j.amepre.2016.08.031_bib23","first-page":"1","article-title":"Surveillance of influenza vaccination coverage\u2014United States, 2007-08 through 2011-12 influenza seasons","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.amepre.2016.08.031_bib24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.vaccine.2008.11.077","article-title":"Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors","volume":"27","author":"Lu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2016.08.031_bib25","unstructured":"CDC. NCHS Health E-Stat. Vaccination coverage estimates from the National Health Interview. www.cdc.gov\/nchs\/data\/hestat\/vaccine_coverage\/vaccine_coverage.htm. Accessed August 11, 2016."},{"issue":"4","key":"10.1016\/j.amepre.2016.08.031_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.amepre.2010.06.004","article-title":"Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989-2008","volume":"39","author":"Lu","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2016.08.031_bib27","unstructured":"CDC. AdultVaxView. www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/index.html. Accessed March 9, 2016."},{"issue":"2","key":"10.1016\/j.amepre.2016.08.031_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/003335491412900203","article-title":"Recommendations from the National Vaccine Advisory Committee: standards for adult immunization practice","volume":"129","year":"2014","journal-title":"Public Health Rep"},{"issue":"9","key":"10.1016\/j.amepre.2016.08.031_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","article-title":"Barriers to the use of herpes zoster vaccine","volume":"152","author":"Hurley","year":"2010","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.amepre.2016.08.031_bib30","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/PHH.0b013e3181b83475","article-title":"State health department structure and pandemic planning","volume":"16","author":"Klaiman","year":"2010","journal-title":"J Public Health Manag Pract"},{"issue":"20","key":"10.1016\/j.amepre.2016.08.031_bib31","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1001\/jama.287.20.2659","article-title":"State trends in health risk factors and receipt of clinical preventive services among U.S. adults during the 1990s","volume":"287","author":"Nelson","year":"2002","journal-title":"JAMA"},{"issue":"SS06","key":"10.1016\/j.amepre.2016.08.031_bib32","first-page":"1","article-title":"State and sex specific prevalence of selected characteristics\u2014Behavioral Risk Factor Surveillance System, 1996 and 1997","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"SS09","key":"10.1016\/j.amepre.2016.08.031_bib33","first-page":"1","article-title":"Surveillance for certain health behaviors among selected local areas\u2014United States, Behavioral Risk Factor Surveillance System, 2011","volume":"63","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2016.08.031_bib34","unstructured":"CDC. FluVaxView. www.cdc.gov\/flu\/fluvaxview\/. Accessed March 9, 2016."},{"key":"10.1016\/j.amepre.2016.08.031_bib35","unstructured":"Guide to Community Preventive Services. www.thecommunityguide.org\/index.html. Accessed February 11, 2016."},{"issue":"33","key":"10.1016\/j.amepre.2016.08.031_bib36","first-page":"729","article-title":"Update on recommendations for use of herpes zoster vaccine","volume":"63","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"10.1016\/j.amepre.2016.08.031_bib37","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.165.16.1849","article-title":"Influenza vaccination trends among adults 65 years or older in the United States, 1989-2002","volume":"165","author":"Lu","year":"2005","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.amepre.2016.08.031_bib38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.amepre.2005.08.012","article-title":"Influenza and pneumococcal vaccination of adults aged \u226565: racial\/ethnic differences","volume":"29","author":"Singleton","year":"2005","journal-title":"Am J Prev Med"},{"issue":"18","key":"10.1016\/j.amepre.2016.08.031_bib39","first-page":"509","article-title":"Hepatitis B vaccination coverage among adults\u2014United States, 2004","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"suppl 4","key":"10.1016\/j.amepre.2016.08.031_bib40","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1016\/j.amepre.2015.03.005","article-title":"Racial and ethnic disparities in vaccination coverage among adult populations\u2014United States, 2012","volume":"49(6)","author":"Lu","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2016.08.031_bib41","unstructured":"Public Health England. Herpes zoster (shingles) immunization program 2013\/2014: report from England. www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/383018\/ShinglesReport2014.pdf. Accessed March 9, 2016."},{"issue":"2","key":"10.1016\/j.amepre.2016.08.031_bib42","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2105\/AJPH.93.2.324","article-title":"Racial\/ethnic differences in adult vaccination among individuals with diabetes","volume":"93","author":"Egede","year":"2003","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.amepre.2016.08.031_bib43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.amepre.2014.12.008","article-title":"Impact of health insurance status on vaccination coverage among adult populations\u2014United States, 2012","volume":"48","author":"Lu","year":"2015","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.amepre.2016.08.031_bib44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/jwh.2011.2876","article-title":"Gender differences in utilization of preventive care services in the United States","volume":"21","author":"Vaidya","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"10.1016\/j.amepre.2016.08.031_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00005650-199905000-00009","article-title":"Influenza and pneumococcal vaccine receipt in older persons with chronic disease: a population-based study","volume":"37","author":"Peterson","year":"1999","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.amepre.2016.08.031_bib46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0749-3797(18)30500-2","article-title":"Participation in health promotion programs by the rural elderly","volume":"11","author":"Lave","year":"1995","journal-title":"Am J Prev Med"},{"issue":"40","key":"10.1016\/j.amepre.2016.08.031_bib47","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1016\/j.vaccine.2011.07.030","article-title":"Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009","volume":"29","author":"Lu","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.amepre.2016.08.031_bib48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/aje\/kwr376","article-title":"Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009","volume":"175","author":"Lu","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.amepre.2016.08.031_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2105\/AJPH.93.1.130","article-title":"Intermittent lack of health insurance coverage and use of preventive services","volume":"93","author":"Sudano","year":"2003","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amepre.2016.08.031_bib50","unstructured":"Beal AC, Doty MM, Hernandez SE, Shea KK, Davis K. Closing the divide: how medical homes promote equity in health care\u2014results from the Commonwealth Fund 2006 Health Care Quality Survey. The commonwealth Fund, New York, NY. www.commonwealthfund.org\/publications\/fund-reports\/2007\/jun\/closing-the-divide--how-medical-homes-promote-equity-in-health-care--results-from-the-commonwealth-f. Accessed February 11, 2016."},{"issue":"37","key":"10.1016\/j.amepre.2016.08.031_bib51","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1016\/j.vaccine.2013.06.041","article-title":"Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?","volume":"31","author":"Rolnick","year":"2013","journal-title":"Vaccine"},{"issue":"suppl","key":"10.1016\/j.amepre.2016.08.031_bib52","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.ophtha.2007.10.015","article-title":"Preventing herpes zoster through vaccination","volume":"115(2)","author":"Gelb","year":"2008","journal-title":"Ophthalmology"},{"issue":"suppl","key":"10.1016\/j.amepre.2016.08.031_bib53","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.jaad.2007.09.017","article-title":"Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.","volume":"57(6)","author":"Betts","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.amepre.2016.08.031_bib54","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1370\/afm.1185","article-title":"Young vaccines provided by family physicians","volume":"8","author":"Campos-Outcalt","year":"2010","journal-title":"Ann Fam Med"},{"issue":"1","key":"10.1016\/j.amepre.2016.08.031_bib55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1331\/JAPhA.2009.08030","article-title":"Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective","volume":"49","author":"Wood","year":"2009","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.amepre.2016.08.031_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1331\/JAPhA.2013.12019","article-title":"Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies","volume":"53","author":"Wang","year":"2013","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.amepre.2016.08.031_bib57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1331\/JAPhA.2013.11097","article-title":"Advocating zoster vaccination in a community pharmacy through use of personal selling","volume":"53","author":"Bryan","year":"2013","journal-title":"J Am Pharm Assoc"},{"issue":"9","key":"10.1016\/j.amepre.2016.08.031_bib58","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2013.02.018","article-title":"Improving herpes zoster vaccination rates through use of a clinical pharmacist and a personal health record","volume":"126","author":"Otsuka","year":"2013","journal-title":"Am J Med"},{"issue":"suppl","key":"10.1016\/j.amepre.2016.08.031_bib59","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amepre.2005.02.016","article-title":"Task Force on Community Preventive Services: interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review","volume":"28(5)","author":"Ndiaye","year":"2005","journal-title":"Am J Prev Med"},{"issue":"suppl","key":"10.1016\/j.amepre.2016.08.031_bib60","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.amepre.2005.02.012","article-title":"Task Force on Community Preventive Services: methods for conducting systematic reviews of targeted vaccination strategies for the guide to community preventive services","volume":"28(5)","author":"Ndiaye","year":"2005","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.amepre.2016.08.031_bib61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0749-3797(03)00120-X","article-title":"Standards for adult immunization practice","volume":"25","author":"Poland","year":"2003","journal-title":"Am J Prev Med"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379716303889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379716303889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T11:44:53Z","timestamp":1568461493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379716303889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0749379716303889"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2016.08.031","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National and State-Specific Shingles Vaccination Among Adults Aged \u226560 Years","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2016.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine","name":"copyright","label":"Copyright"}]}}